ASX Growth Companies With High Insider Ownership And Up To 120% Earnings Growth

The Australian market has shown varied performance recently, with the ASX200 modestly increasing by 0.1% over the past week. Notably, sectors such as IT and financials have seen gains, while materials faced declines. In this context of fluctuating sector performance, companies with high insider ownership can be particularly compelling. These firms often benefit from aligned interests between shareholders and management, which might be crucial in navigating through current market conditions and leveraging opportunities for substantial earnings growth.

Top 10 Growth Companies With High Insider Ownership In Australia

Name	Insider Ownership	Earnings Growth
Hartshead Resources (ASX:HHR)	13.9%	86.3%
Cettire (ASX:CTT)	28.7%	26.7%
Acrux (ASX:ACR)	14.6%	115.3%
SiteMinder (ASX:SDR)	11.3%	75.1%
Botanix Pharmaceuticals (ASX:BOT)	10%	120.9%
Plenti Group (ASX:PLT)	12.8%	106.4%
Change Financial (ASX:CCA)	26.6%	76.4%
Hillgrove Resources (ASX:HGO)	10.4%	45.4%
Biome Australia (ASX:BIO)	34.5%	114.4%
Liontown Resources (ASX:LTR)	16.4%	52.2%

Click here to see the full list of 90 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Botanix Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★★

Overview: Botanix Pharmaceuticals Limited, based in Australia, focuses on the research and development of dermatological and antimicrobial products with a market capitalization of approximately A$624.46 million.

Operations: The company generates revenue primarily from its research and development activities in dermatology and antimicrobial products, totaling A$0.44 million.

Insider Ownership: 10%

Earnings Growth Forecast: 120.9% p.a.

Botanix Pharmaceuticals, despite its modest revenue of A$437K, is poised for substantial growth with earnings expected to increase by 120.89% annually. The company's recent follow-on equity offerings totaling A$70 million suggest a strategic push towards scaling operations. Although past shareholder dilution raises concerns, the forecasted return on equity at 43.9% and profitability within three years highlight strong potential amid high insider ownership dynamics in Australia's growth sectors.

• Get an in-depth perspective on Botanix Pharmaceuticals' performance by reading our analyst estimates report here.

• According our valuation report, there's an indication that Botanix Pharmaceuticals' share price might be on the expensive side.

ASX:BOT Ownership Breakdown as at Jun 2024

Flight Centre Travel Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Flight Centre Travel Group Limited operates as a travel retailer serving both leisure and corporate sectors across various regions including Australia, New Zealand, the Americas, Europe, the Middle East, Africa, and Asia with a market cap of approximately A$4.44 billion.

Operations: The company's revenue is primarily derived from two segments: leisure travel, generating A$1.28 billion, and corporate travel, contributing A$1.06 billion.

Insider Ownership: 13.3%

Earnings Growth Forecast: 18.8% p.a.

Flight Centre Travel Group, trading below its fair value by 18.5%, shows promising financial trends with earnings and revenue growth forecasts outpacing the Australian market. Expected annual earnings growth of 18.8% and revenue increases at 9.7% per year highlight its potential despite not reaching very high growth thresholds. With a projected high return on equity of 21.8% in three years, FLT demonstrates solid prospects although it lacks significant recent insider trading activity to underscore commitment from insiders directly.

• Unlock comprehensive insights into our analysis of Flight Centre Travel Group stock in this growth report.

• Our comprehensive valuation report raises the possibility that Flight Centre Travel Group is priced higher than what may be justified by its financials.

ASX:FLT Earnings and Revenue Growth as at Jun 2024

IPD Group

Simply Wall St Growth Rating: ★★★★★☆

Overview: IPD Group Limited, operating in Australia, specializes in the distribution of electrical equipment and has a market capitalization of approximately A$484.85 million.

Operations: The company generates revenue through its Products Division, which brought in A$215.98 million, and its Services Division, which contributed A$20.79 million.

Insider Ownership: 28.1%

Earnings Growth Forecast: 25.9% p.a.

IPD Group, trading at 7.6% below its estimated fair value, exhibits promising financial metrics with revenue expected to grow by 23.6% annually, surpassing the Australian market's 5.4%. Earnings are also projected to increase significantly at a rate of 25.9% per year, outpacing the market average of 13.8%. However, concerns arise as shareholders have experienced dilution over the past year and there has been significant insider selling recently, signaling potential caution among insiders despite these growth figures.

• Take a closer look at IPD Group's potential here in our earnings growth report.

• The analysis detailed in our IPD Group valuation report hints at an inflated share price compared to its estimated value.

ASX:IPG Earnings and Revenue Growth as at Jun 2024

Make It Happen

• Unlock more gems! Our Fast Growing ASX Companies With High Insider Ownership screener has unearthed 87 more companies for you to explore.Click here to unveil our expertly curated list of 90 Fast Growing ASX Companies With High Insider Ownership.

• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.

• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ASX:BOT ASX:FLT and ASX:IPG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com